Levels of Structural Integration Mediate the Impact of Metacognition on Functioning in Non-affective Psychosis: Adding a Psychodynamic Perspective to the Metacognitive Approach.
MAS-A
Operationalized Psychodynamic Diagnosis
internalized object representations
mentalizing abilities
psychic structure
psychosocial functioning
psychotherapy of psychosis
synthetic metacognition
Journal
Frontiers in psychology
ISSN: 1664-1078
Titre abrégé: Front Psychol
Pays: Switzerland
ID NLM: 101550902
Informations de publication
Date de publication:
2020
2020
Historique:
received:
31
10
2019
accepted:
04
02
2020
entrez:
11
3
2020
pubmed:
11
3
2020
medline:
11
3
2020
Statut:
epublish
Résumé
Synthetic metacognition is defined by integrative and contextualizing processes of discrete reflexive moments. These processes are supposed to be needed to meet intrapsychic as well as interpersonal challenges and to meaningfully include psychotic experience in a personal life narrative. A substantial body of evidence has linked this phenomenon to psychosocial functioning and treatment options were developed. The concept of synthetic metacognition, measured with the Metacognition Assessment Scale-Abbreviated (MAS-A), rises hope to bridge gaps between therapeutic orientations and shares valuable parallels to modern psychodynamic constructs, especially the 'levels of structural integration' of the Operationalized Psychodynamic Diagnosis (OPD-2). As theoretical distinctions remain, aim of this study was to compare the predictive value of both constructs with regard to psychosocial functioning of patients with non-affective psychoses, measured with the International Classification of Functioning, Disability and Health (MINI-ICF-APP). It was further explored if levels of structural integration (OPD-LSIA) would mediate the impact of metacognition (MAS-A) on function (MINI-ICF-APP). Expert ratings of synthetic metacognition (MAS-A), the OPD-2 'levels of structural integration' axis (OPD-LSIA), psychosocial functioning (MINI-ICF-APP) and assessments of general cognition and symptoms were applied to 100 individuals with non-affective psychoses. Whereas both, MAS-A and OPD-LSIA, significantly predicted MINI-ICF-APP beyond cognition and symptoms, OPD-LSIA explained a higher share of variance and mediated the impact of MAS-A on MINI-ICF-APP. Levels of structural integration, including the quality of internalized object representations and unconscious interpersonal schemas, might therefore be considered as valuable predictors of social functioning and as one therapeutic focus in patients with non-affective psychoses. Structural integration might go beyond and form the base of a person's actual reflexive and metacognitive capabilities. Psychotherapeutic procedures specific for psychoses may promote and challenge a patient's metacognitive capacities, but should equally take the need for maturing structural skills into account. Modern psychodynamic approaches to psychosis are shortly presented, providing concepts and techniques for the implicit regulation of interpersonal experience and aiming at structural integration in this patient group.
Identifiants
pubmed: 32153475
doi: 10.3389/fpsyg.2020.00269
pmc: PMC7047329
doi:
Types de publication
Journal Article
Langues
eng
Pagination
269Informations de copyright
Copyright © 2020 Bröcker, Bayer, Stuke, Just, Bertram, Funcke, Grimm, Lempa, von Haebler and Montag.
Références
Schizophr Bull. 2000;26(1):119-36
pubmed: 10755673
Acta Psychiatr Scand. 2013 Mar;127(3):239-47
pubmed: 22967227
Schizophr Res. 2011 Sep;131(1-3):75-81
pubmed: 21700430
Psychiatry Res. 2016 Nov 30;245:15-21
pubmed: 27526312
Int Rev Psychiatry. 2007 Feb;19(1):13-23
pubmed: 17365155
Clin Psychol Psychother. 2014 Sep-Oct;21(5):465-73
pubmed: 23754780
Isr J Psychiatry Relat Sci. 2014;51(1):63-7
pubmed: 24858636
J Psychiatr Res. 1999 Sep-Oct;33(5):433-43
pubmed: 10504012
Schizophr Res. 2004 Dec 15;72(1):41-51
pubmed: 15531406
Schizophr Bull. 2006 Oct;32 Suppl 1:S44-63
pubmed: 16916889
Schizophr Bull. 2014 May;40(3):487-91
pubmed: 24636965
Personal Disord. 2020 Mar;11(2):79-90
pubmed: 31580097
Schizophr Res. 2016 Dec;178(1-3):74-79
pubmed: 27591821
Psychol Med. 2015;45(12):2675-84
pubmed: 26165380
Eur Psychiatry. 2017 Oct;46:33-41
pubmed: 28992534
J Clin Psychol. 2015 Feb;71(2):117-24
pubmed: 25557317
Schizophr Res. 2018 Dec;202:260-266
pubmed: 30001972
Am J Psychoanal. 2019 Sep;79(3):284-303
pubmed: 31332242
J Clin Psychol. 2015 Feb;71(2):146-56
pubmed: 25557537
Schizophr Res. 2012 May;137(1-3):246-50
pubmed: 22356801
Psychiatry. 2012 Winter;75(4):331-41
pubmed: 23244011
Psychopathology. 2014;47(3):185-93
pubmed: 24192300
Psychiatry Res. 2014 Mar 30;215(3):760-5
pubmed: 24495572
Br J Psychiatry. 2013 Nov;203(5):327-33
pubmed: 24187067
Psychol Psychother. 2010 Sep;83(Pt 3):303-15
pubmed: 20170602
Dev Psychopathol. 2009 Fall;21(4):1355-81
pubmed: 19825272
Acta Psychiatr Scand. 2010 Nov;122(5):405-13
pubmed: 20346074
Schizophr Bull. 2015 Jul;41(4):879-91
pubmed: 25399026
Am J Psychother. 2012;66(1):85-106
pubmed: 22523795
World J Psychiatry. 2018 Mar 22;8(1):1-11
pubmed: 29568726
Schizophr Bull. 2013 Jan;39(1):102-11
pubmed: 21765165
Arch Gen Psychiatry. 1982 Jul;39(7):784-8
pubmed: 7165477
Schizophr Res. 2015 Feb;161(2-3):386-91
pubmed: 25499045
Schizophr Res. 2018 Nov;201:20-26
pubmed: 29903626
Curr Opin Psychiatry. 2007 Nov;20(6):619-25
pubmed: 17921766
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Acta Psychiatr Scand. 2005 Jul;112(1):64-71
pubmed: 15952947
Psychol Psychother. 2017 Sep;90(3):401-418
pubmed: 28334488
J Behav Ther Exp Psychiatry. 2014 Jun;45(2):280-4
pubmed: 24440585
Personal Disord. 2020 May;11(3):191-201
pubmed: 31478718
Psychol Psychother. 2019 Sep;92(3):342-358
pubmed: 29624832
J Nerv Ment Dis. 2018 Apr;206(4):263-269
pubmed: 29377848
Psychopathology. 2007;40(4):209-20
pubmed: 17396047
Psychiatry Res. 2013 Oct 30;209(3):381-5
pubmed: 23688962
Schizophr Bull. 2018 Oct 17;44(6):1235-1244
pubmed: 29267940
Int J Psychoanal. 2019 Feb;100(1):99-127
pubmed: 33945717
JAMA Psychiatry. 2014 Oct;71(10):1103-11
pubmed: 25103718
Schizophr Bull. 2019 Jan 1;45(1):37-47
pubmed: 30388270
Z Psychosom Med Psychother. 2010;56(2):150-62
pubmed: 20623460
Front Hum Neurosci. 2016 Aug 22;10:406
pubmed: 27597820
Neurosci Biobehav Rev. 2019 Oct;105:212-219
pubmed: 31415864
BMC Psychol. 2018 Jul 17;6(1):32
pubmed: 30016999
World Psychiatry. 2019 Jun;18(2):146-161
pubmed: 31059632
Schizophr Bull. 2005 Oct;31(4):882-7
pubmed: 16135561
J Clin Psychol. 2009 Aug;65(8):803-14
pubmed: 19572277
Br J Psychiatry. 2014 Jul;205(1):60-7
pubmed: 24723630
J Nerv Ment Dis. 2018 Dec;206(12):907-912
pubmed: 30439777
J Consult Clin Psychol. 1991 Jun;59(3):400-9
pubmed: 2071725
Psychiatry Res. 2018 Jan;259:463-469
pubmed: 29145104
Psychol Med. 2011 Sep;41(9):1823-32
pubmed: 21275083
Schizophr Res Cogn. 2019 Apr 24;19:100142
pubmed: 31828019
Arch Gen Psychiatry. 1982 Jul;39(7):789-94
pubmed: 7165478
J Nerv Ment Dis. 1969 Jun;148(6):569-85
pubmed: 5772722
J Pers Assess. 2012;94(5):522-32
pubmed: 22808938
BMC Psychiatry. 2016 Jun 08;16:191
pubmed: 27278250
Psychopathology. 1995;28(1):7-17
pubmed: 7871123
Z Psychosom Med Psychoanal. 1995;41(3):197-212
pubmed: 7571881
Psychol Med. 2019 Jan;49(2):303-313
pubmed: 29692285
Psychiatry. 2014 Summer;77(2):155-68
pubmed: 24865198
Br J Psychiatry. 2014 Jan;204(1):20-9
pubmed: 24385461
Z Psychosom Med Psychother. 2009;55(1):84-96
pubmed: 19353514
Schizophr Res. 2006 Jul;85(1-3):280-7
pubmed: 16730429
Conscious Cogn. 2008 Sep;17(3):778-89
pubmed: 18394921
Psychol Res Behav Manag. 2018 Sep 05;11:341-351
pubmed: 30233262
Psychol Psychother. 2017 Dec;90(4):668-685
pubmed: 28544223